Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

CRPS rehabilitation with graded imagery and desensitization tailored to you

Official title: Clinical and Cerebral Changes Following Multifaceted Rehabilitation of Complex Regional Pain Syndrome: A Single-Case Experimental Design.

Run by University Hospital of North Norway · NCT02753335 · Data updated 2026-11-12

This study tests a personalized rehab program for CRPS to see if it improves daily functioning and pain, with MRI to explore brain changes.

More Complex Regional Pain Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment12 (estimated)
SponsorUniversity Hospital of North Norway
Academic / other
Locations1 site (Tromsø)
StatusRecruiting
StartedSeptember 2016
Main results expectedMay 2030
Study endsNovember 15, 2032
Registry record updatedOctober 8, 2026
Trial IDNCT02753335 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–70 with a single- limb CRPS lasting more than 3 months who are not on high-dose opioids or with contraindicating health conditions.

Probably not a fit

Patients with multiple limbs affected, uncontrolled severe psychiatric illness, or contraindications to MRI may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will deliver an individualized rehabilitation program for CRPS that combines graded motor imagery and tactile desensitization within a psychologically informed care framework. The study uses a randomized multiple-baseline single-case design to track how each participant responds before and after starting treatment. Outcomes include daily CRPS interference, pain levels, and limb function, measured repeatedly, with additional assessments at baseline and 12 months. For a subset, MRI will compare brain structure with healthy controls and monitor changes over time. Two work packages jointly address clinical effects and neuroimaging under real-world clinical conditions.

Why it matters

Potential benefit: If successful, the program could reduce pain and improve daily function for people with CRPS and may reveal brain changes associated with rehabilitation.

How similar studies have gone: Previous similar approaches using graded motor imagery and desensitization have shown signals of benefit in CRPS, though evidence remains variable and this study includes innovative MRI outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older. For participants included in WP2 (MRI), the maximum age is 70 years.
* Diagnosis of Complex Regional Pain Syndrome (CRPS) according to the Budapest criteria.
* CRPS affecting a single upper or lower limb.
* Triggering trauma or onset of pain more than 3 months before inclusion.

Exclusion Criteria:

* Drug abuse.
* Malignant or progressive disease, systemic disease, or neurodegenerative disease.
* Other severe pain conditions.
* Severe anxiety or depression.
* Disabling fatigue or myalgic encephalomyelitis (ME).
* Use of opioid medication exceeding 100 mg oral morphine equivalents (OMEQ).

Additional Exclusion Criteria for WP2 (MRI):

* History of seizures.
* Neurological or neurosurgical disorders.
* Significant cardiac or systemic illness.
* Implanted metallic or electronic devices incompatible with MRI.
* Diagnosis of a developmental disorder.
* Current use of antipsychotic medications, benzodiazepines, or other pharmacological agents that may influence MRI measurements.
* Pregnancy or lactation.
* Phobia of MRI examination.

Where it's running

  • University Hospital of North Norway
    Tromsø, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.